← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Sunnybrook Research Institute
Toronto, ON
$20,542,642
Total funding
17
Grants
Funding over time
peak $4.7M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,119,841 · 10
DOD$4,422,801 · 7
By mechanism
R01$15,822,954 · 9
—$4,422,801 · 7
R21$296,887 · 1
Investigators at Sunnybrook Research Institute
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Largest grants
BUILDING A BETTER MODEL: A PERSONALIZED BREAST CANCER RISK MODEL INCORPORATING BREAST DENSITY TO STRATFY RISK AND IMPROVE APPLICATION OF RESOURCES$1,142,712
· FY2011 · Department of Defense
THE RELATIONSHIP BETWEEN TYPE OF OPIOID USED DURING CRITICAL ILLNESS AND TRANSITION TO CHRONIC PAIN$912,262
· FY2021 · Defense Health Agency
Sleep, Circadian Rhythms, and Mechanisms of Cognitive Decline in the Human Brain$695,765
R01 · FY2018 · AG
Sleep, Circadian Rhythms, and Mechanisms of Cognitive Decline in the Human Brain$693,555
R01 · FY2020 · AG
Sleep, Circadian Rhythms, and Mechanisms of Cognitive Decline in the Human Brain$687,355
R01 · FY2021 · AG
INHIBITING INTERACTION OF PNUTS WITH THE MYC FAMILY OF ONCOPROTEINS TO EFFECTIVELY TARGET BREAST CANCER$660,414
· FY2021 · Defense Health Agency
PREDICTING SENSITIVITY TO DNA REPAIR INHIBITION IN SHORT-TERM PATIENT-DERIVED OVARIAN CANCER ORGANOIDS BEYOND PARP PROGRESSION$603,378
· FY2021 · Defense Health Agency
Acute Pain Management and Long-term Opioid Use after Surgery$594,249
R01 · FY2017 · DA
Sleep, Circadian Rhythms, and Mechanisms of Cognitive Decline in the Human Brain$593,611
R01 · FY2019 · AG
Sleep, Circadian Rhythms, and Mechanisms of Cognitive Decline in the Human Brain$581,117
R01 · FY2017 · AG
Imaging the effects of transcranial alternatingcurrent stimulation in an experimental model of Alzheimer's Disease$555,058
R01 · FY2024 · AG
The development and validation of a novel tool for the assessment of bulbar dysfunction in ALS$551,619
R01 · FY2020 · DC
Imaging the effects of transcranial alternatingcurrent stimulation in an experimental model of Alzheimer's Disease$546,676
R01 · FY2025 · AG
AI-assisted multimodal digital remote screening for bulbar ALS to support timely referral to SLP care$528,090
R01 · FY2025 · DC
Acute Pain Management and Long-term Opioid Use after Surgery$491,141
R01 · FY2018 · DA
AUGMENTATION OF APOPTOSIS IN HIGH-GRADE SEROUS EPITHELIAL OVARIAN CANCER (HGSC) BY INHIBITION OF ANTIAPOPTOSIS PROTEINS AND DNA REPAIR$485,882
· FY2021 · Defense Health Agency
Acute Pain Management and Long-term Opioid Use after Surgery$485,662
R01 · FY2019 · DA
The development and validation of a novel tool for the assessment of bulbar dysfunction in ALS$481,005
R01 · FY2021 · DC
The development and validation of a novel tool for the assessment of bulbar dysfunction in ALS$481,005
R01 · FY2022 · DC
Acute Pain Management and Long-term Opioid Use after Surgery$475,888
R01 · FY2020 · DA